Skip to main content

Table 2 Activation of human and zebrafish PXRs by pregnane steroids and related compounds

From: Evolution of pharmacologic specificity in the pregnane X receptor

Cmp. #

Compound

hPXR Activity

hPXR Efficacy

zfPXR Activity

zfPXR Efficacy

Toxicity

PR1

5β-Pregnan-3α,20α-diol (5β-pregnanediol)

5.29

0.34

None

 

100

PR2

5β-Pregnan-3,20-dione (5β-pregnanedione)

5.59

0.97

6.08

0.85

None

PR3

4-Pregnen-11β,21-diol-3,20-dione (corticosterone)

5.00

0.54

None

 

None

PR4

4-Pregnen-17,21-diol-3,20-dione (cortexolone)

4.64

0.49

None

 

None

PR5

4-Pregnen-11β,21-diol-3,18,20-trione (aldosterone)

4.26

0.21

None

 

None

PR6

4-Pregnen-17,21-diol-3,11,20-trione (cortisone)

4.16

0.28

None

 

200

PR7

4-Pregnen-3,20-dione (progesterone)

4.83

0.57

None

 

200

PR8

4-Pregnen-17-ol-3,20-dione

4.75

0.7

None

 

None

PR9

4-Pregnen-21-ol-3,20-dione (cortexone)

5.61

0.3

None

 

200

PR10

4-Pregnen-3β,17,21-triol-3,20-dione (cortisol)

4.32

0.66

None

 

None

PR11

5-Pregnen-3β,17-diol-20-one

4.47

0.36

None

 

None

PR12

5-Pregnen-3β-diol-20-one (pregnenolone)

5.64

1.26

6.32

2.05

None

PR13

5-Pregnen-16α-cyano-3β-ol-20-one

None

 

None

 

None

PR14

5α-Pregnan-3α-ol-20-one (allopregnanolone)

5.38

0.46

5.40

0.30

None

PR15

5α-Pregnan-3α,20α-diol (allopregnanediol)

4.28

0.16

4.58

0.29

None

PR16

5β-Pregnan-3α,20α-diol-3-glucosiduronate (pregnanediol glucuconide)

4.26

0.17

4.78

1.42

None

PR17

5β-Pregnan-3α,11β,17,20α-21-pentol (cortol)

4.33

0.83

3.95

0.98

200

PR18

5β-Pregnan-3α,17,20α-21-tetrol-11-one (cortolone)

4.35

0.72

4.34

0.25

200

PR19

5β-Pregnan-3α,17,21-triol-11,20-dione

4.28

0.8

4.43

0.33

None

PR20

5α-Pregnan-3α,11β,21-triol-20-one

4.90

0.26

None

 

None

PR21

4-Pregnen-17α,20β-diol-3,20-dione

None

 

None

 

200

PR22

4-Pregnen-20β-ol-3,20-dione-17α-sulfate

5.73

0.66

None

 

None

PR23

5β-Pregnan-3α,20β-diol

5.42

0.49

5.95

0.25

None

PR24

5β-Pregnan-3α,11β,17,21-tetrol-20-one

4.33

0.73

3.94

0.11

None

PR25

5β-Pregnan-3α-ol-20-one

4.98

0.55

6.64

1.22

100

PR26

5-Pregnen-20-one-3β-sulfate

None

 

4.95

0.23

None

PR27

4-Estren-17α-ethynyl-18-homo-17β-ol-3-one (levonorgestrel)

5.37

0.35

6.00

0.86

None

PR28

4-Estren-17α-ethynyl-17β-ol-3-one (norethindrone)

4.59

0.32

5.85

0.40

None

PR29

1,4-Pregnadien-9α-fluoro-16α-methyl-11β,17,21-triol-3,20-dione (dexamethasone)

4.39

0.83

None

 

None

  1. Activities are in -log(EC50), with EC50 in molar units for the activation of human or zebrafish PXR. Efficacy is relative to 10 μM rifampicin (human PXR) or 20 μM 5α-androstan-3α-ol (zebrafish PXR) which are assigned an efficacy of 1.0. Toxicity is the lowest concentration in micromolar that produced significant toxicity in the HepG2 cells.